水頭症シャント市場の2030年までの予測：製品タイプ、シャントタイプ、年齢層、エンドユーザー、地域別の世界分析

Stratistics MRCによると、世界の水頭症シャント市場は2023年に3億2,220万米ドルを占め、予測期間中にCAGR 6.1％で成長し、2030年には4億8,760万米ドルに達すると予測されています。

過剰な脳脊髄液の貯留を伴う精神疾患を治療するために臨床で使用される器具は、水頭症シャントと呼ばれます。頭蓋内圧因子の拡大は、頭蓋骨のこの状態の結果です。これらの装置による体液の回収は、脳のストレスを軽減するのに役立ちます。シャントは、余分な脳脊髄液を脳から体内の別の場所（通常は腹腔）へ迂回させ、そこで自然に吸収されるように設計された、外科的に植え込まれた装置です。

米国生化学分子生物学会が2021年3月に発表した論文によると、米国では毎年約280万人が外傷性脳損傷（TBI）を負い、約28万人が入院を余儀なくされています。

シャント技術の進歩

プログラム可能で調節可能なシャントシステムの開発、生体適合性と耐用年数の向上を目指した新素材の利用、低侵襲手術技術の導入など、シャント技術の進歩は多岐にわたる。プログラム可能なシャントは、シャント留置後に流量設定を調整できるため、患者の水頭症症状をより柔軟に管理できます。さらに、シャントの設計に革新的な素材を取り入れることで、シャントの性能が向上し、感染や閉塞などの合併症のリスクが軽減されます。

コストの制約

脳内の脳脊髄液の貯留を特徴とする水頭症では、症状を緩和するためにシャント装置による外科的介入が必要となることが多いです。手術、装置の埋め込み、継続的なメンテナンスなど、シャント造設に伴う高額な費用は、患者にも医療提供者にも経済的負担を強います。しかし、特にヘルスケアインフラが不十分な地域では、保険適用範囲が限られていることが問題をさらに悪化させ、必要不可欠な治療へのアクセスを遅らせたり、拒否したりする可能性があります。

低侵襲手術への需要の高まり

低侵襲手術は、従来の開頭手術に比べて、外傷の軽減、回復時間の短縮、入院期間の短縮、感染や出血などの合併症リスクの最小化など、いくつかの利点があります。過剰な脳脊髄液の貯留を管理するためにシャント植え込み術を必要とすることが多い水頭症では、低侵襲的アプローチは従来の方法よりも侵襲性の低い代替手段となります。このような手技では通常、切開創を小さくし、特殊な器具を使用し、時には内視鏡ガイドを使用することで、外科医がより正確にシャントを設置し、周辺組織の破壊を最小限に抑えることができます。

治療への不十分なアクセス

脳内に脳脊髄液が貯留する水頭症では、症状を緩和するためにシャントによる外科的治療が必要となることが多いです。しかし、特に医療が行き届いていない地域や発展途上国では、医療インフラに格差があるため、タイムリーな診断、治療、フォローアップケアへのアクセスが制限されています。限られたヘルスケア施設、十分な訓練を受けた医療従事者、経済的な制約などの課題が、この課題の一因となっています。その結果、多くの水頭症患者が必要なシャント手術を受けられなかったり、手術を受けるのが遅れたりし、罹患率や死亡率の上昇につながっています。

COVID-19の影響：

世界中のヘルスケアシステムがパンデミック対策にリソースを振り向けたため、COVID-19患者を優先し、感染リスクを最小限に抑えるために、水頭症を含む選択的手術が延期または中止されました。このため、シャントの移植や交換が減少し、市場が低迷しました。さらに、必要でない医療処置の制限と、ウイルス感染を恐れて病院を訪れたがらない患者の存在が、需要をさらに減退させました。

予測期間中、水頭症カテーテル分野が最大になる見込み

水頭症カテーテル分野は、カテーテルの設計と材料の進歩により、シャントシステムの有効性と寿命が改善され、患者の転帰が向上し、再手術の必要性が減少したため、予測期間中、市場で最大のシェアを占めました。先天性水頭症や正常圧水頭症などの疾患の有病率の増加は、効果的な治療オプションに対する需要を煽り、水頭症シャント術の世界の増加につながっています。さらに、カテーテル製造の技術革新によって低侵襲技術が開発され、シャント設置術がより安全で患者にとって利用しやすいものとなっています。

心室腹膜シャント分野は予測期間中に最も高いCAGRが見込まれる

脳室シャント部門は、水頭症（脳室内に脳脊髄液が貯留することを特徴とする状態）の治療に有効であり、広く採用されているため、予測期間中に収益性の高い成長を遂げる見込みです。VPシャントは、余分な体液を脳室から腹腔に迂回させ、そこで自然に体内に吸収されるようにすることで、低侵襲のソリューションを提供します。このアプローチは頭蓋内圧を緩和するだけでなく、頭痛、吐き気、認知障害といった水頭症に伴う症状の緩和にも役立ちます。

最もシェアの高い地域

水頭症シャント市場は、神経疾患の有病率の上昇、侵襲性の低い治療法に対する患者の嗜好、ヘルスケアコストの上昇、シャント技術の進歩につながる研究開発努力の向上などの理由から、北米で最も急速に成長しており、推定期間で最大の売上シェアを占めています。例えば、メディケア＆メディケイドサービスセンター（CMS）は、2022年の米国の医療費は7.5％になると予測しています。支出が初めて1兆米ドルを超えるのは2023年と予想されています。

CAGRが最も高い地域：

アジア太平洋地域のヘルスケア・インフラの改善、手術件数の増加、医療機器ポートフォリオを拡大するための政府との合意により、アジア太平洋市場は予測期間中に利益を上げながら成長すると予想されます。例えば、日本とインドの首相は2022年3月、医療機器製造の合弁事業を支援するため、5年間の財政計画と420億米ドルの投資を承認しました。医療費の高騰により、インドの医療制度は、看護ケアから疾病管理のための予防ケアへのサービス・ポートフォリオのシフトを目の当たりにしています。

無料カスタマイズサービス：

本レポートをご購読のお客様には、以下の無料カスタマイズオプションのいずれかをご利用いただけます：

• 企業プロファイル
  • 追加市場プレーヤーの包括的プロファイリング（3社まで）
  • 主要企業のSWOT分析（3社まで）
• 地域セグメンテーション
  • 顧客の関心に応じた主要国の市場推計・予測・CAGR（注：フィージビリティチェックによる）
• 競合ベンチマーキング
  • 製品ポートフォリオ、地理的プレゼンス、戦略的提携に基づく主要企業のベンチマーキング

目次

第1章 エグゼクティブサマリー

第2章 序文

• 概要
• ステークホルダー
• 調査範囲
• 調査手法
  • データマイニング
  • データ分析
  • データ検証
  • 調査アプローチ
• 調査ソース
  • 1次調査ソース
  • 2次調査資料
  • 前提条件

第3章 市場動向分析

• 促進要因
• 抑制要因
• 機会
• 脅威
• 製品分析
• エンドユーザー分析
• 新興市場
• COVID-19の影響

第4章 ポーターのファイブフォース分析

• 供給企業の交渉力
• 買い手の交渉力
• 代替品の脅威
• 新規参入業者の脅威
• 競争企業間の敵対関係

第5章 世界の水頭症シャント市場：製品別

• 水頭症カテーテル
  • 抗菌カテーテル
  • 標準カテーテル
• 水頭症バルブ
  • 固定圧力バルブ
  • 調整可能圧力バルブ
• その他の製品

第6章 世界の水頭症シャント市場：シャントタイプ別

• 脳室胸膜シャント
• 腰腹膜シャント
• 心室房シャント
• 脳室腹腔シャント
• その他のシャントタイプ

第7章 世界の水頭症シャント市場：年齢グループ別

• 成人
• 小児

第8章 世界の水頭症シャント市場：エンドユーザー別

• 外来手術センター
• 病院
• その他のエンドユーザー

第9章 世界の水頭症シャント市場：地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • イタリア
  • フランス
  • スペイン
  • その他欧州
• アジア太平洋地域
  • 日本
  • 中国
  • インド
  • オーストラリア
  • ニュージーランド
  • 韓国
  • その他アジア太平洋地域
• 南米
  • アルゼンチン
  • ブラジル
  • チリ
  • その他南米
• 中東・アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • カタール
  • 南アフリカ
  • その他中東とアフリカ

第10章 主な発展

• 契約、パートナーシップ、コラボレーション、合弁事業
• 買収と合併
• 新製品発売
• 事業拡大
• その他の主要戦略

第11章 企業プロファイリング

• Aesculap, Inc
• B. Braun Melsungen AG
• Christoph Miethke GmbH & Co. KG
• G. Surgiwear Ltd
• Integra LifeSciences
• Johnson & Johnson
• Medtronic
• Natus Medical Incorporated
• Sophysa
• Spiegelberg GmbH & Co. KG

List of Tables

• Table 1 Global Hydrocephalus Shunt Market Outlook, By Region (2021-2030) ($MN)
• Table 2 Global Hydrocephalus Shunt Market Outlook, By Product (2021-2030) ($MN)
• Table 3 Global Hydrocephalus Shunt Market Outlook, By Hydrocephalus Catheter (2021-2030) ($MN)
• Table 4 Global Hydrocephalus Shunt Market Outlook, By Antimicrobial Catheters (2021-2030) ($MN)
• Table 5 Global Hydrocephalus Shunt Market Outlook, By Standard Catheters (2021-2030) ($MN)
• Table 6 Global Hydrocephalus Shunt Market Outlook, By Hydrocephalus Valves (2021-2030) ($MN)
• Table 7 Global Hydrocephalus Shunt Market Outlook, By Fix Pressure Valves (2021-2030) ($MN)
• Table 8 Global Hydrocephalus Shunt Market Outlook, By Adjustable Pressure Valves (2021-2030) ($MN)
• Table 9 Global Hydrocephalus Shunt Market Outlook, By Other Products (2021-2030) ($MN)
• Table 10 Global Hydrocephalus Shunt Market Outlook, By Shunt Type (2021-2030) ($MN)
• Table 11 Global Hydrocephalus Shunt Market Outlook, By Ventriculopleural Shunts (2021-2030) ($MN)
• Table 12 Global Hydrocephalus Shunt Market Outlook, By Lumboperitoneal Shunts (2021-2030) ($MN)
• Table 13 Global Hydrocephalus Shunt Market Outlook, By Ventriculoatrial Shunts (2021-2030) ($MN)
• Table 14 Global Hydrocephalus Shunt Market Outlook, By Ventriculoperitoneal Shunts (2021-2030) ($MN)
• Table 15 Global Hydrocephalus Shunt Market Outlook, By Other Shunt Types (2021-2030) ($MN)
• Table 16 Global Hydrocephalus Shunt Market Outlook, By Age Group (2021-2030) ($MN)
• Table 17 Global Hydrocephalus Shunt Market Outlook, By Adult (2021-2030) ($MN)
• Table 18 Global Hydrocephalus Shunt Market Outlook, By Pediatric (2021-2030) ($MN)
• Table 19 Global Hydrocephalus Shunt Market Outlook, By End User (2021-2030) ($MN)
• Table 20 Global Hydrocephalus Shunt Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
• Table 21 Global Hydrocephalus Shunt Market Outlook, By Hospitals (2021-2030) ($MN)
• Table 22 Global Hydrocephalus Shunt Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 23 North America Hydrocephalus Shunt Market Outlook, By Country (2021-2030) ($MN)
• Table 24 North America Hydrocephalus Shunt Market Outlook, By Product (2021-2030) ($MN)
• Table 25 North America Hydrocephalus Shunt Market Outlook, By Hydrocephalus Catheter (2021-2030) ($MN)
• Table 26 North America Hydrocephalus Shunt Market Outlook, By Antimicrobial Catheters (2021-2030) ($MN)
• Table 27 North America Hydrocephalus Shunt Market Outlook, By Standard Catheters (2021-2030) ($MN)
• Table 28 North America Hydrocephalus Shunt Market Outlook, By Hydrocephalus Valves (2021-2030) ($MN)
• Table 29 North America Hydrocephalus Shunt Market Outlook, By Fix Pressure Valves (2021-2030) ($MN)
• Table 30 North America Hydrocephalus Shunt Market Outlook, By Adjustable Pressure Valves (2021-2030) ($MN)
• Table 31 North America Hydrocephalus Shunt Market Outlook, By Other Products (2021-2030) ($MN)
• Table 32 North America Hydrocephalus Shunt Market Outlook, By Shunt Type (2021-2030) ($MN)
• Table 33 North America Hydrocephalus Shunt Market Outlook, By Ventriculopleural Shunts (2021-2030) ($MN)
• Table 34 North America Hydrocephalus Shunt Market Outlook, By Lumboperitoneal Shunts (2021-2030) ($MN)
• Table 35 North America Hydrocephalus Shunt Market Outlook, By Ventriculoatrial Shunts (2021-2030) ($MN)
• Table 36 North America Hydrocephalus Shunt Market Outlook, By Ventriculoperitoneal Shunts (2021-2030) ($MN)
• Table 37 North America Hydrocephalus Shunt Market Outlook, By Other Shunt Types (2021-2030) ($MN)
• Table 38 North America Hydrocephalus Shunt Market Outlook, By Age Group (2021-2030) ($MN)
• Table 39 North America Hydrocephalus Shunt Market Outlook, By Adult (2021-2030) ($MN)
• Table 40 North America Hydrocephalus Shunt Market Outlook, By Pediatric (2021-2030) ($MN)
• Table 41 North America Hydrocephalus Shunt Market Outlook, By End User (2021-2030) ($MN)
• Table 42 North America Hydrocephalus Shunt Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
• Table 43 North America Hydrocephalus Shunt Market Outlook, By Hospitals (2021-2030) ($MN)
• Table 44 North America Hydrocephalus Shunt Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 45 Europe Hydrocephalus Shunt Market Outlook, By Country (2021-2030) ($MN)
• Table 46 Europe Hydrocephalus Shunt Market Outlook, By Product (2021-2030) ($MN)
• Table 47 Europe Hydrocephalus Shunt Market Outlook, By Hydrocephalus Catheter (2021-2030) ($MN)
• Table 48 Europe Hydrocephalus Shunt Market Outlook, By Antimicrobial Catheters (2021-2030) ($MN)
• Table 49 Europe Hydrocephalus Shunt Market Outlook, By Standard Catheters (2021-2030) ($MN)
• Table 50 Europe Hydrocephalus Shunt Market Outlook, By Hydrocephalus Valves (2021-2030) ($MN)
• Table 51 Europe Hydrocephalus Shunt Market Outlook, By Fix Pressure Valves (2021-2030) ($MN)
• Table 52 Europe Hydrocephalus Shunt Market Outlook, By Adjustable Pressure Valves (2021-2030) ($MN)
• Table 53 Europe Hydrocephalus Shunt Market Outlook, By Other Products (2021-2030) ($MN)
• Table 54 Europe Hydrocephalus Shunt Market Outlook, By Shunt Type (2021-2030) ($MN)
• Table 55 Europe Hydrocephalus Shunt Market Outlook, By Ventriculopleural Shunts (2021-2030) ($MN)
• Table 56 Europe Hydrocephalus Shunt Market Outlook, By Lumboperitoneal Shunts (2021-2030) ($MN)
• Table 57 Europe Hydrocephalus Shunt Market Outlook, By Ventriculoatrial Shunts (2021-2030) ($MN)
• Table 58 Europe Hydrocephalus Shunt Market Outlook, By Ventriculoperitoneal Shunts (2021-2030) ($MN)
• Table 59 Europe Hydrocephalus Shunt Market Outlook, By Other Shunt Types (2021-2030) ($MN)
• Table 60 Europe Hydrocephalus Shunt Market Outlook, By Age Group (2021-2030) ($MN)
• Table 61 Europe Hydrocephalus Shunt Market Outlook, By Adult (2021-2030) ($MN)
• Table 62 Europe Hydrocephalus Shunt Market Outlook, By Pediatric (2021-2030) ($MN)
• Table 63 Europe Hydrocephalus Shunt Market Outlook, By End User (2021-2030) ($MN)
• Table 64 Europe Hydrocephalus Shunt Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
• Table 65 Europe Hydrocephalus Shunt Market Outlook, By Hospitals (2021-2030) ($MN)
• Table 66 Europe Hydrocephalus Shunt Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 67 Asia Pacific Hydrocephalus Shunt Market Outlook, By Country (2021-2030) ($MN)
• Table 68 Asia Pacific Hydrocephalus Shunt Market Outlook, By Product (2021-2030) ($MN)
• Table 69 Asia Pacific Hydrocephalus Shunt Market Outlook, By Hydrocephalus Catheter (2021-2030) ($MN)
• Table 70 Asia Pacific Hydrocephalus Shunt Market Outlook, By Antimicrobial Catheters (2021-2030) ($MN)
• Table 71 Asia Pacific Hydrocephalus Shunt Market Outlook, By Standard Catheters (2021-2030) ($MN)
• Table 72 Asia Pacific Hydrocephalus Shunt Market Outlook, By Hydrocephalus Valves (2021-2030) ($MN)
• Table 73 Asia Pacific Hydrocephalus Shunt Market Outlook, By Fix Pressure Valves (2021-2030) ($MN)
• Table 74 Asia Pacific Hydrocephalus Shunt Market Outlook, By Adjustable Pressure Valves (2021-2030) ($MN)
• Table 75 Asia Pacific Hydrocephalus Shunt Market Outlook, By Other Products (2021-2030) ($MN)
• Table 76 Asia Pacific Hydrocephalus Shunt Market Outlook, By Shunt Type (2021-2030) ($MN)
• Table 77 Asia Pacific Hydrocephalus Shunt Market Outlook, By Ventriculopleural Shunts (2021-2030) ($MN)
• Table 78 Asia Pacific Hydrocephalus Shunt Market Outlook, By Lumboperitoneal Shunts (2021-2030) ($MN)
• Table 79 Asia Pacific Hydrocephalus Shunt Market Outlook, By Ventriculoatrial Shunts (2021-2030) ($MN)
• Table 80 Asia Pacific Hydrocephalus Shunt Market Outlook, By Ventriculoperitoneal Shunts (2021-2030) ($MN)
• Table 81 Asia Pacific Hydrocephalus Shunt Market Outlook, By Other Shunt Types (2021-2030) ($MN)
• Table 82 Asia Pacific Hydrocephalus Shunt Market Outlook, By Age Group (2021-2030) ($MN)
• Table 83 Asia Pacific Hydrocephalus Shunt Market Outlook, By Adult (2021-2030) ($MN)
• Table 84 Asia Pacific Hydrocephalus Shunt Market Outlook, By Pediatric (2021-2030) ($MN)
• Table 85 Asia Pacific Hydrocephalus Shunt Market Outlook, By End User (2021-2030) ($MN)
• Table 86 Asia Pacific Hydrocephalus Shunt Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
• Table 87 Asia Pacific Hydrocephalus Shunt Market Outlook, By Hospitals (2021-2030) ($MN)
• Table 88 Asia Pacific Hydrocephalus Shunt Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 89 South America Hydrocephalus Shunt Market Outlook, By Country (2021-2030) ($MN)
• Table 90 South America Hydrocephalus Shunt Market Outlook, By Product (2021-2030) ($MN)
• Table 91 South America Hydrocephalus Shunt Market Outlook, By Hydrocephalus Catheter (2021-2030) ($MN)
• Table 92 South America Hydrocephalus Shunt Market Outlook, By Antimicrobial Catheters (2021-2030) ($MN)
• Table 93 South America Hydrocephalus Shunt Market Outlook, By Standard Catheters (2021-2030) ($MN)
• Table 94 South America Hydrocephalus Shunt Market Outlook, By Hydrocephalus Valves (2021-2030) ($MN)
• Table 95 South America Hydrocephalus Shunt Market Outlook, By Fix Pressure Valves (2021-2030) ($MN)
• Table 96 South America Hydrocephalus Shunt Market Outlook, By Adjustable Pressure Valves (2021-2030) ($MN)
• Table 97 South America Hydrocephalus Shunt Market Outlook, By Other Products (2021-2030) ($MN)
• Table 98 South America Hydrocephalus Shunt Market Outlook, By Shunt Type (2021-2030) ($MN)
• Table 99 South America Hydrocephalus Shunt Market Outlook, By Ventriculopleural Shunts (2021-2030) ($MN)
• Table 100 South America Hydrocephalus Shunt Market Outlook, By Lumboperitoneal Shunts (2021-2030) ($MN)
• Table 101 South America Hydrocephalus Shunt Market Outlook, By Ventriculoatrial Shunts (2021-2030) ($MN)
• Table 102 South America Hydrocephalus Shunt Market Outlook, By Ventriculoperitoneal Shunts (2021-2030) ($MN)
• Table 103 South America Hydrocephalus Shunt Market Outlook, By Other Shunt Types (2021-2030) ($MN)
• Table 104 South America Hydrocephalus Shunt Market Outlook, By Age Group (2021-2030) ($MN)
• Table 105 South America Hydrocephalus Shunt Market Outlook, By Adult (2021-2030) ($MN)
• Table 106 South America Hydrocephalus Shunt Market Outlook, By Pediatric (2021-2030) ($MN)
• Table 107 South America Hydrocephalus Shunt Market Outlook, By End User (2021-2030) ($MN)
• Table 108 South America Hydrocephalus Shunt Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
• Table 109 South America Hydrocephalus Shunt Market Outlook, By Hospitals (2021-2030) ($MN)
• Table 110 South America Hydrocephalus Shunt Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 111 Middle East & Africa Hydrocephalus Shunt Market Outlook, By Country (2021-2030) ($MN)
• Table 112 Middle East & Africa Hydrocephalus Shunt Market Outlook, By Product (2021-2030) ($MN)
• Table 113 Middle East & Africa Hydrocephalus Shunt Market Outlook, By Hydrocephalus Catheter (2021-2030) ($MN)
• Table 114 Middle East & Africa Hydrocephalus Shunt Market Outlook, By Antimicrobial Catheters (2021-2030) ($MN)
• Table 115 Middle East & Africa Hydrocephalus Shunt Market Outlook, By Standard Catheters (2021-2030) ($MN)
• Table 116 Middle East & Africa Hydrocephalus Shunt Market Outlook, By Hydrocephalus Valves (2021-2030) ($MN)
• Table 117 Middle East & Africa Hydrocephalus Shunt Market Outlook, By Fix Pressure Valves (2021-2030) ($MN)
• Table 118 Middle East & Africa Hydrocephalus Shunt Market Outlook, By Adjustable Pressure Valves (2021-2030) ($MN)
• Table 119 Middle East & Africa Hydrocephalus Shunt Market Outlook, By Other Products (2021-2030) ($MN)
• Table 120 Middle East & Africa Hydrocephalus Shunt Market Outlook, By Shunt Type (2021-2030) ($MN)
• Table 121 Middle East & Africa Hydrocephalus Shunt Market Outlook, By Ventriculopleural Shunts (2021-2030) ($MN)
• Table 122 Middle East & Africa Hydrocephalus Shunt Market Outlook, By Lumboperitoneal Shunts (2021-2030) ($MN)
• Table 123 Middle East & Africa Hydrocephalus Shunt Market Outlook, By Ventriculoatrial Shunts (2021-2030) ($MN)
• Table 124 Middle East & Africa Hydrocephalus Shunt Market Outlook, By Ventriculoperitoneal Shunts (2021-2030) ($MN)
• Table 125 Middle East & Africa Hydrocephalus Shunt Market Outlook, By Other Shunt Types (2021-2030) ($MN)
• Table 126 Middle East & Africa Hydrocephalus Shunt Market Outlook, By Age Group (2021-2030) ($MN)
• Table 127 Middle East & Africa Hydrocephalus Shunt Market Outlook, By Adult (2021-2030) ($MN)
• Table 128 Middle East & Africa Hydrocephalus Shunt Market Outlook, By Pediatric (2021-2030) ($MN)
• Table 129 Middle East & Africa Hydrocephalus Shunt Market Outlook, By End User (2021-2030) ($MN)
• Table 130 Middle East & Africa Hydrocephalus Shunt Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
• Table 131 Middle East & Africa Hydrocephalus Shunt Market Outlook, By Hospitals (2021-2030) ($MN)
• Table 132 Middle East & Africa Hydrocephalus Shunt Market Outlook, By Other End Users (2021-2030) ($MN)

According to Stratistics MRC, the Global Hydrocephalus Shunt Market is accounted for $322.2 million in 2023 and is expected to reach $487.6 million by 2030 growing at a CAGR of 6.1% during the forecast period. An apparatus used in clinical practice to help treat a mental illness involving excessive cerebrospinal fluid collection is referred to as a hydrocephalus shunt. An expanded intracranial pressing factor is the result of this condition in the skull. The fluid collection caused by these devices helps reduce stress in the brain. Shunts are surgically implanted devices designed to divert excess cerebrospinal fluid from the brain to another part of the body, typically the abdominal cavity, where it can be absorbed naturally.

According to an article published by the American Society for Biochemistry and Molecular Biology in March 2021, in the United States, about 2.8 million people sustain a traumatic brain injury (TBI) every year, with some 280,000 resulting in hospitalizations.

Market Dynamics:

Driver:

Advancements in shunt technology

The advancements encompass a wide range of improvements, including the development of programmable and adjustable shunt systems, utilization of novel materials for improved biocompatibility and longevity, and the introduction of minimally invasive surgical techniques. Programmable shunts offer the ability to adjust flow settings post-implantation, providing greater flexibility in managing patients' hydrocephalus symptoms. Additionally, the integration of innovative materials into shunt designs enhances their performance and reduces the risk of complications such as infection and blockage.

Restraint:

Cost constraints

Hydrocephalus, a condition characterized by an accumulation of cerebrospinal fluid in the brain, often requires surgical intervention with shunt devices to alleviate symptoms. The high cost associated with shunt placement, including surgery, device implantation, and ongoing maintenance, poses financial burdens for patients and healthcare providers alike. However, limited insurance coverage, particularly in regions with inadequate healthcare infrastructure, further exacerbates the issue, potentially delaying or denying access to essential treatment.

Opportunity:

Growing demand for minimally invasive surgical procedures

Minimally invasive techniques offer several advantages over traditional open surgeries, including reduced trauma, faster recovery times, shorter hospital stays, and minimized risk of complications such as infection and bleeding. In the context of hydrocephalus, where patients often require shunt implantation to manage excess cerebrospinal fluid buildup, minimally invasive approaches provide a less invasive alternative to traditional methods. These techniques typically involve smaller incisions, specialized tools, and sometimes even endoscopic guidance, allowing surgeons to place shunts with greater precision and minimal disruption to surrounding tissues.

Threat:

Inadequate access to care

Hydrocephalus, a condition characterized by an accumulation of cerebrospinal fluid within the brain, often requires surgical intervention with shunts to alleviate symptoms. However, disparities in healthcare infrastructure, particularly in underserved regions and developing countries, limit access to timely diagnosis, treatment, and follow-up care. Factors such as limited healthcare facilities, insufficient trained medical personnel, and financial constraints contribute to this challenge. Consequently, many individuals with hydrocephalus lack access to essential shunt surgeries or experience delays in receiving them, leading to increased morbidity and mortality rates.

Covid-19 Impact:

As healthcare systems worldwide redirected resources to combat the pandemic, elective surgeries, including those for hydrocephalus, were postponed or canceled to prioritize COVID-19 patients and minimize transmission risks. This led to a decrease in shunt implantations and replacements, resulting in a downturn in the market. Moreover, restrictions on non-essential medical procedures, coupled with patients' reluctance to visit hospitals due to fear of contracting the virus, further dampened demand.

The Hydrocephalus Catheter segment is expected to be the largest during the forecast period

Hydrocephalus Catheter segment commanded the largest share of the market over the projection period as advancements in catheter design and materials have improved the efficacy and longevity of shunt systems, enhancing patient outcomes and reducing the need for revision surgeries. The increasing prevalence of conditions such as congenital hydrocephalus and normal pressure hydrocephalus is fueling demand for effective treatment options, leading to a rising number of hydrocephalus shunt procedures worldwide. Moreover, technological innovations in catheter manufacturing have allowed for the development of minimally invasive techniques, making shunt placement procedures safer and more accessible to patients.

The Ventriculoperitoneal Shunts segment is expected to have the highest CAGR during the forecast period

Ventriculoperitoneal Shunts segment is poised to witness profitable growth during the overcast period due to its effectiveness and widespread adoption in treating hydrocephalus-a condition characterized by the accumulation of cerebrospinal fluid in the brain's ventricles. VP shunts offer a minimally invasive solution by diverting excess fluid from the brain's ventricles to the peritoneal cavity, where it can be naturally absorbed by the body. This approach not only relieves intracranial pressure but also helps alleviate symptoms associated with hydrocephalus, such as headaches, nausea, and cognitive impairment.

Region with largest share:

Because of the rising prevalence of neurological disorders, patients' preference for less invasive procedures, rising healthcare costs, and improved research and development efforts leading to advancements in shunt technology, the hydrocephalus shunts market has grown most rapidly in North America, accounting for the largest revenue share over the extrapolated period. The Centers for Medicare & Medicaid Services (CMS), for instance, projected that in 2022, health spending in the United States would be 7.5%. The first time that spending is expected to surpass $1 trillion USD is in 2023.

Region with highest CAGR:

Because of the region's improved healthcare infrastructure, rising number of surgeries, and government agreements to expand the medical device portfolio, the Asia Pacific market is expected to grow profitably over the projected period. For instance, the prime ministers of Japan and India approved a five-year financial plan and an investment of USD 42 billion in March 2022 to support a joint venture in medical equipment production. Due to rising healthcare costs, India's healthcare system is witnessing a shift in its service portfolio from nursing care to preventative care for disease control.

Key players in the market

Some of the key players in Hydrocephalus Shunt market include Aesculap, Inc, B. Braun Melsungen AG, Christoph Miethke GmbH & Co. KG, G. Surgiwear Ltd, Integra LifeSciences, Johnson & Johnson, Medtronic, Natus Medical Incorporated, Sophysa and Spiegelberg GmbH & Co. KG.

Key Developments:

In November 2023, for young patients suffering from hydrocephalus-a neurological disorder that results in an accumulation of cerebral fluid in the interior spaces of the brain which often requires repeated hospital stays-surgeons at Intermountain Primary Children's Hospital successfully placed a novel brain shunt accessory, becoming the first hospital in the U.S. to accomplish the same.

In October 2023, through its Blueprint MedTech initiative, the NINDS (National Institute of Neurological Disorders and Stroke) of the National Institutes of Health (NIH) awarded Rhaeos, Inc. a USD 1.5 million grant. With this award, the company will continue to develop its FDA-designated breakthrough medical technology, which aims to revolutionize the treatment of hydrocephalus, a brain disorder that affects more than a million people in the U.S.

In July 2023, Cerevasc Inc. partnered with Lianmedical Co. Ltd. to introduce its medical devices for neurological diseases in Asia. Lianmedical marketed Cerevasc's eshunt system and related products in mainland China, Hong Kong, Taiwan, and Macau, facilitating percutaneous transvenous-transdural access to the central nervous system.

Products Covered:

• Hydrocephalus Catheter
• Hydrocephalus Valves
• Other Products

Shunt Types Covered:

• Ventriculopleural Shunts
• Lumboperitoneal Shunts
• Ventriculoatrial Shunts
• Ventriculoperitoneal Shunts
• Other Shunt Types

Age Groups Covered:

• Adult
• Pediatric

End Users Covered:

• Ambulatory Surgical Centers
• Hospitals
• Other End Users

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Product Analysis
• 3.7 End User Analysis
• 3.8 Emerging Markets
• 3.9 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Hydrocephalus Shunt Market, By Product

• 5.1 Introduction
• 5.2 Hydrocephalus Catheter
  • 5.2.1 Antimicrobial Catheters
  • 5.2.2 Standard Catheters
• 5.3 Hydrocephalus Valves
  • 5.3.1 Fix Pressure Valves
  • 5.3.2 Adjustable Pressure Valves
• 5.4 Other Products

6 Global Hydrocephalus Shunt Market, By Shunt Type

• 6.1 Introduction
• 6.2 Ventriculopleural Shunts
• 6.3 Lumboperitoneal Shunts
• 6.4 Ventriculoatrial Shunts
• 6.5 Ventriculoperitoneal Shunts
• 6.6 Other Shunt Types

7 Global Hydrocephalus Shunt Market, By Age Group

• 7.1 Introduction
• 7.2 Adult
• 7.3 Pediatric

8 Global Hydrocephalus Shunt Market, By End User

• 8.1 Introduction
• 8.2 Ambulatory Surgical Centers
• 8.3 Hospitals
• 8.4 Other End Users

9 Global Hydrocephalus Shunt Market, By Geography

• 9.1 Introduction
• 9.2 North America
  • 9.2.1 US
  • 9.2.2 Canada
  • 9.2.3 Mexico
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 Italy
  • 9.3.4 France
  • 9.3.5 Spain
  • 9.3.6 Rest of Europe
• 9.4 Asia Pacific
  • 9.4.1 Japan
  • 9.4.2 China
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 New Zealand
  • 9.4.6 South Korea
  • 9.4.7 Rest of Asia Pacific
• 9.5 South America
  • 9.5.1 Argentina
  • 9.5.2 Brazil
  • 9.5.3 Chile
  • 9.5.4 Rest of South America
• 9.6 Middle East & Africa
  • 9.6.1 Saudi Arabia
  • 9.6.2 UAE
  • 9.6.3 Qatar
  • 9.6.4 South Africa
  • 9.6.5 Rest of Middle East & Africa

10 Key Developments

• 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 10.2 Acquisitions & Mergers
• 10.3 New Product Launch
• 10.4 Expansions
• 10.5 Other Key Strategies

11 Company Profiling

• 11.1 Aesculap, Inc
• 11.2 B. Braun Melsungen AG
• 11.3 Christoph Miethke GmbH & Co. KG
• 11.4 G. Surgiwear Ltd
• 11.5 Integra LifeSciences
• 11.6 Johnson & Johnson
• 11.7 Medtronic
• 11.8 Natus Medical Incorporated
• 11.9 Sophysa
• 11.10 Spiegelberg GmbH & Co. KG